I agree that this site is using cookies. You can find further informations here.
X
Vidarsdottir, Linda
27  results:
Search for persons X
?
1

MicroRNA-190b Targets RFWD3 in Estrogen Receptor–Positive B..:

Frick, Elisabet Alexandra ; Kristjansdottir, Karen ; Ragnarsdottir, Snaedís...
Breast Cancer: Basic and Clinical Research.  18 (2024)  - p. , 2024
Link: https://doi.org/10.1177/..
 
?
2

Estrogen receptor-positive breast cancer and adverse outcom..:

Vidarsdottir, Linda ; Olafsdottir, Elinborg J. ; Barkardottir, Rosa B....
npj Breast Cancer.  9 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
3

RNAi prodrugs decrease elevated mRNA levels of Polo‐like ki..:

Kolosenko, Iryna ; Goroshchuk, Oksana ; Vidarsdottir, Linda...
The FASEB Journal.  35 (2021)  5 - p. , 2021
Link: https://doi.org/10.1096/..
 
?
4

PTENP1-AS contributes to BRAF inhibitor resistance and is a..:

Vidarsdottir, Linda ; Azimi, Alireza ; Das, Ishani...
Scientific Reports.  11 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
5

Thermal proteome profiling identifies PIP4K2A and ZADH2 as ..:

Goroshchuk, Oksana ; Kolosenko, Iryna ; Kunold, Elena...
The FASEB Journal.  35 (2021)  7 - p. , 2021
Link: https://doi.org/10.1096/..
 
?
6

Targeting Plk1 with siRNNs in primary cells from pediatric ..:

Goroshchuk, Oksana ; Vidarsdottir, Linda ; Björklund, Ann-Charlotte...
Scientific Reports.  10 (2020)  1 - p. , 2020
Link: https://doi.org/10.1038/..
 
?
7

ALL-166: Novel RNAi Prodrugs Targeting Plk1 Induce Specific..:

Goroshchuk, Oksana ; Vidarsdottir, Linda ; Björklund, Ann-Charlotte...
Clinical Lymphoma Myeloma and Leukemia.  20 (2020)  - p. S163 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Silencing of CEBPB-AS1 modulates CEBPB expression and resen..:

Vidarsdottir, Linda ; Fernandes, Rita Valador ; Zachariadis, Vasilios...
Melanoma Research.  30 (2020)  5 - p. 443-454 , 2020
Link: https://doi.org/10.1097/..
 
?
9

Polo-like kinases and acute leukemia:

Goroshchuk, Oksana ; Kolosenko, Iryna ; Vidarsdottir, Linda..
Oncogene.  38 (2018)  1 - p. 1-16 , 2018
Link: https://doi.org/10.1038/..
 
?
10

The molecular dynamics of long noncoding RNA control of tra..:

Lister, Nicholas ; Shevchenko, Galina ; Walshe, James L....
Proceedings of the National Academy of Sciences.  114 (2017)  37 - p. 9942-9947 , 2017
Link: https://doi.org/10.1073/..
 
?
11

The molecular dynamics of long noncoding RNA control of tra..:

Lister, Nicholas ; Shevchenko, Galina ; Walshe, James L....
Proceedings of the National Academy of Sciences of the United States of America.  114 (2017)  37 - p. 9942-9947 , 2017
Link: https://www.jstor.org/st..
 
?
12

Sensitivity of BRCA2 mutated human cell lines to Aurora kin..:

Vidarsdottir, Linda ; Steingrimsdottir, Gudridur ; Bodvarsdottir, Sigridur Klara..
Investigational New Drugs.  30 (2010)  2 - p. 425-434 , 2010
Link: https://doi.org/10.1007/..
 
?
13

Breast cancer risk associated with AURKA 91T→A polymorphism..:

Vidarsdottir, Linda ; Bodvarsdottir, Sigridur K. ; Hilmarsdottir, Holmfridur..
Cancer Letters.  250 (2007)  2 - p. 206-212 , 2007
Link: https://doi.org/10.1016/..
 
?
14

Estrogen receptor-positive breast cancer and adverse outcom..:

Vidarsdottir, Linda ; Olafsdottir, Elinborg J ; Barkardóttir, Rósa Björk...
npj Breast Cancer; 9(1).  , 2023
Link: https://hdl.handle.net/2..
 
?
15

PTENP1-AS contributes to BRAF inhibitor resistance and is a..:

Vidarsdottir, Linda ; Azimi, Alireza ; Das, Ishani...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155038/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
1-15